Literature DB >> 33446749

Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide.

Lena Dalal1,2, Abdul Wahab Allaf3, Hind El-Zein4,3.   

Abstract

Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size was 17.9 ± 4.5 nm. The theoretical model was used to calculate the amounts of the carrier (Avicel PH101) and coating materials (Aerosil 200) to prepare liquisolid powder. Carrier/coating materials ratio of 5/1 was used and Ludipress was added to the solid system, thus tablets with hardness of 45 ± 2 N were obtained. Liquisolid tablets showed 2-folds increase in drug release as compared to the generic tablets after 60 min in HCl 0.1 N using USP apparatus-II. Furosemide loaded SNEDDS tablets have great prospects for further in vivo studies, and the theoretical model is useful for calculating the adequate amounts of adsorbents required to solidify these systems.

Entities:  

Year:  2021        PMID: 33446749      PMCID: PMC7809212          DOI: 10.1038/s41598-020-79940-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  31 in total

1.  Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.

Authors:  Kazi Mohsin; Michelle A Long; Colin W Pouton
Journal:  J Pharm Sci       Date:  2009-10       Impact factor: 3.534

Review 2.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

3.  Self-emulsifying pellets: relations between kinetic parameters of drug release and emulsion reconstitution-influence of formulation variables.

Authors:  Ioannis Nikolakakis; Stavros Malamataris
Journal:  J Pharm Sci       Date:  2014-03-04       Impact factor: 3.534

4.  Identification of phases of various oil, surfactant/ co-surfactants and water system by ternary phase diagram.

Authors:  Haroon K Syed; Kok K Peh
Journal:  Acta Pol Pharm       Date:  2014 Mar-Apr       Impact factor: 0.330

5.  Enhanced oral delivery of risperidone through a novel self-nanoemulsifying powder (SNEP) formulations: in-vitro and ex-vivo assessment.

Authors:  Srikanth Bandi; Krishna Sanka; Vasudha Bakshi
Journal:  J Microencapsul       Date:  2016-08-28       Impact factor: 3.142

6.  Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.

Authors:  Kazi Mohsin
Journal:  AAPS PharmSciTech       Date:  2012-05-01       Impact factor: 3.246

Review 7.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

8.  Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).

Authors:  Saeed Alqahtani; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2014-06-17       Impact factor: 1.880

9.  Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.

Authors:  Elisma Spamer; Douw G Müller; Philippus L Wessels; Johannes P Venter
Journal:  Eur J Pharm Sci       Date:  2002-09       Impact factor: 4.384

10.  Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes.

Authors:  Wenzhan Yang; Melgardt M de Villiers
Journal:  J Pharm Pharmacol       Date:  2004-06       Impact factor: 3.765

View more
  3 in total

1.  Self-nanoemulsifying formulation for oral delivery of sildenafil: effect on physicochemical attributes and in vivo pharmacokinetics.

Authors:  Sanyog Jain; Narinder Kumar; Reena Sharma; Rohan Ghadi; Tushar Date; Nallamothu Bhargavi; Dasharath Chaudhari; Sameer S Katiyar
Journal:  Drug Deliv Transl Res       Date:  2022-10-12       Impact factor: 5.671

Review 2.  Nanocarriers for delivery of siRNA as gene silencing mediator.

Authors:  Aideé Morales-Becerril; Liliana Aranda-Lara; Keila Isaac-Olivé; Blanca E Ocampo-García; Enrique Morales-Ávila
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

Review 3.  Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.

Authors:  Mahir Mohammed; Nikita Devnarain; Eman Elhassan; Thirumala Govender
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.